Photodynamic therapy of lung cancer, where are we?

Research output: Contribution to journalReview articlepeer-review

17 Citations (Scopus)

Abstract

Lung cancer remains the leading threat of death globally, killing more people than colon, breast, and prostate cancers combined. Novel lung cancer treatments are being researched because of the ineffectiveness of conventional cancer treatments and the failure of remission. Photodynamic therapy (PDT), a cancer treatment method that is still underutilized, is a sophisticated cancer treatment that shows selective destruction of malignant cells via reactive oxygen species production. PDT has been extensively studied in vitro and clinically. Various PDT strategies have been shown to be effective in the treatment of lung cancer. PDT has been shown in clinical trials to considerably enhance the quality of life and survival in individuals with incurable malignancies. Furthermore, PDT, in conjunction with the use of nanoparticles, is currently being researched for use as an effective cancer treatment, with promising results. PDT and the new avenue of nanoPDT, which are novel treatment options for lung cancer with such promising results, should be tested in clinical trials to determine their efficacy and side effects. In this review, we examine the status and future potentials of nanoPDT in lung cancer treatment.

Original languageEnglish
Article number932098
JournalFrontiers in Pharmacology
Volume13
DOIs
Publication statusPublished - 30 Aug 2022

Keywords

  • lung cancer
  • nanoPDT
  • nanomaterials
  • nanomedicine
  • nanotechnology
  • photodynamic therapy
  • photosensitizer

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Photodynamic therapy of lung cancer, where are we?'. Together they form a unique fingerprint.

Cite this